Detalhe da pesquisa
1.
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer.
Cell
; 175(5): 1244-1258.e26, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30454645
2.
Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases.
FASEB J
; 38(5): e23536, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470360
3.
Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
Leuk Res
; 140: 107485, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579483
4.
Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees.
EMBO Rep
; 12(3): 238-43, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21331099
5.
The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation.
Adv Sci (Weinh)
; 10(32): e2301939, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752764
6.
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.
Sci Rep
; 13(1): 16443, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777587
7.
Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells.
Cancers (Basel)
; 14(14)2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884401
8.
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Clin Epigenetics
; 13(1): 54, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691794
9.
Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
Cancer Chemother Pharmacol
; 88(5): 845-856, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331108
10.
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity.
Mol Cancer Ther
; 20(1): 37-49, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087510
11.
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.
J Exp Clin Cancer Res
; 38(1): 251, 2019 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31196146
12.
Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
Oncol Res
; 17(5): 223-30, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18980019
13.
DNA Methylation-Targeted Drugs.
Cancer J
; 23(5): 270-276, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28926427
14.
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
Mol Cancer Ther
; 16(2): 397-407, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27980103
15.
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Clin Cancer Res
; 22(24): 6236-6246, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256309
16.
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
Cancer Res
; 76(6): 1494-505, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719529
17.
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
J Natl Cancer Inst
; 108(2)2015 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568194
18.
Epigenetic synergy between decitabine and platinum derivatives.
Clin Epigenetics
; 7: 97, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366234
19.
Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.
Epigenetics
; 10(9): 872-81, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224146
20.
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition.
Genome Biol
; 14(12): R144, 2013 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24367927